217 related articles for article (PubMed ID: 17948087)
1. A synopsis of research in cardiac apoptosis and its application to congestive heart failure.
Khoynezhad A; Jalali Z; Tortolani AJ
Tex Heart Inst J; 2007; 34(3):352-9. PubMed ID: 17948087
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis: pathophysiology and therapeutic implications for the cardiac surgeon.
Khoynezhad A; Jalali Z; Tortolani AJ
Ann Thorac Surg; 2004 Sep; 78(3):1109-18. PubMed ID: 15337071
[TBL] [Abstract][Full Text] [Related]
3. Ventricular remodeling in heart failure.
Gaballa MA; Goldman S
J Card Fail; 2002 Dec; 8(6 Suppl):S476-85. PubMed ID: 12555161
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
5. Biologic rationale for the use of beta-blockers in the treatment of heart failure.
Sabbah HN
Heart Fail Rev; 2004 Apr; 9(2):91-7. PubMed ID: 15516856
[TBL] [Abstract][Full Text] [Related]
6. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
Strauer BE
Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in heart failure.
Sabbah HN; Sharov VG
Prog Cardiovasc Dis; 1998; 40(6):549-62. PubMed ID: 9647609
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
[TBL] [Abstract][Full Text] [Related]
10. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
11. Interventional effect of valsartan on expression of inducible cAMP early repressor and phosphodiesterase 3A in rats after myocardial infarction.
Ma D; Fu L; Shen J; Zhou P; Gao Y; Xie R; Li Y; Han Y; Wang Y; Wang F
Eur J Pharmacol; 2009 Jan; 602(2-3):348-54. PubMed ID: 19027736
[TBL] [Abstract][Full Text] [Related]
12. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
13. Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
Yurista SR; Matsuura TR; Silljé HHW; Nijholt KT; McDaid KS; Shewale SV; Leone TC; Newman JC; Verdin E; van Veldhuisen DJ; de Boer RA; Kelly DP; Westenbrink BD
Circ Heart Fail; 2021 Jan; 14(1):e007684. PubMed ID: 33356362
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiologic process of ventricular remodeling: from infarct to failure.
Paul S
Crit Care Nurs Q; 1995 May; 18(1):7-21. PubMed ID: 7719950
[TBL] [Abstract][Full Text] [Related]
15. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
Francis GS
Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937
[TBL] [Abstract][Full Text] [Related]
16. Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress.
Li B; Chi RF; Qin FZ; Guo XF
Exp Physiol; 2016 Aug; 101(8):1050-63. PubMed ID: 27219474
[TBL] [Abstract][Full Text] [Related]
17. Prevention of left ventricular remodelling after acute myocardial infarction: an update.
Rossini R; Senni M; Musumeci G; Ferrazzi P; Gavazzi A
Recent Pat Cardiovasc Drug Discov; 2010 Nov; 5(3):196-207. PubMed ID: 20874671
[TBL] [Abstract][Full Text] [Related]
18. Digitoxin Attenuates Heart Failure, Reduces Myocardial Hypertrophy, and Preserves the Calcium-Binding Proteins in Infarcted Rats.
Picollo CT; Santos AAD; Antonio EL; Silva JMA; Bocalini D; Serra AJ; Ihara SSM; Tucci PJF
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):265-272. PubMed ID: 31714152
[TBL] [Abstract][Full Text] [Related]
19. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.
Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
Chest; 2005 Sep; 128(3):1812-21. PubMed ID: 16162791
[TBL] [Abstract][Full Text] [Related]
20. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.
Li Y; Takemura G; Kosai K; Takahashi T; Okada H; Miyata S; Yuge K; Nagano S; Esaki M; Khai NC; Goto K; Mikami A; Maruyama R; Minatoguchi S; Fujiwara T; Fujiwara H
Circ Res; 2004 Sep; 95(6):627-36. PubMed ID: 15297380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
